Current Search Criteria: Intervention: GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Found 30 matching trials
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females PHASE3 This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Show More Location
Liuzhou center for disease control and prevention
Learn More & Join Trial
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) PHASE3 This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Show More Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Learn More & Join Trial
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years PHASE3 Human papillomavirus (HPV) infection is the most common viral infection of ...
Show More Status
Active Not Recruiting
Location
Centre For Clinical Research, Kemri
Learn More & Join Trial
A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213) PHASE3 This study is designed to evaluate the immunogenicity, safety, and tolerabi...
Show More Location
Yangchun Center For Disease Prevention And Control ( Site 0003)
Learn More & Join Trial
Comparing Health Services Interventions for the Prevention of HPV-related Cancer PHASE4 The study aims to identify global and local determinants of HPV vaccine acc...
Show More Learn More & Join Trial
Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System PHASE2 The goal of this clinical trial is to evaluate the safety and immunogenicit...
Show More Location
Universitas Padjadjaran
Learn More & Join Trial
A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents PHASE4 The main objective is to determine whether immune responses to Tdap (GlaxoS...
Show More Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615
Learn More & Join Trial
A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years PHASE2 A phase II random, double blind, positive and placebo control trail was con...
Show More Location
Guanyun Country CDC
Learn More & Join Trial
Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India PHASE4 The primary study hypothesis wasthat a two-dose human papillomavirus (HPV) ...
Show More Location
MNJ Institute of Oncology & Regional Cancer Center
Learn More & Join Trial
Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study PHASE2 Objective: To evaluate the effectiveness of a combined strategy of human pa...
Show More Location
Instituto Nacional de Salud Publica
Learn More & Join Trial